Combination of sitagliptin and lansoprazole offers clinical benefits for T1D patients
 

Sanford Project researchers have reached a critical milestone in a clinical trial testing a combination of two medications to determine if the drugs can help patients with type 1 diabetes (T1D) keep their blood glucose levels under control with less or no insulin. The full number of patients needed to complete this first trial, termed Restore Pancreatic Insulin Response in type 1 diabetes (REPAIR-T1D), has been reached.

More...

Re: Combination of sitagliptin and lansoprazole offers clinical benefits for T1D pati
 

Oh, my friend was just visiting that has had type I since we were kids back in the (insert long time ago). So excited to share this news with her.